Author

I. Hilgendorf

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Longer-term response to SARS-CoV-2 vaccination after allogeneic blood stem cell transplantation

Recipients of allogeneic haematopoietic stem cell transplantation (alloHSCT) are at increased risk of COVID-19 and lower vaccine immunogenicity. This study assessed vaccine immunogenicity and safety in these patients. We analyzed the serological response after the 2nd and 3rd SARS-CoV-2 vaccination as well as potential...

C. Crodel, Laura Gork, W. Göpel et al. · Journal of Cancer Research a... · 0 citations

Open access Aug 2026

Allogeneic stem cell transplantation after myeloablative conditioning with fludarabine, thiotepa, and cyclophosphamide in relapsed or refractory aggressive B-cell and T-cell lymphomas: results of the prospective ASTRAL study.

While allogeneic stem cell transplantation (alloSCT) remains the only curative option for patients with relapsed T-cell lymphoma, its place in the treatment algorithm of aggressive B-cell lymphoma is changing. This multicentre, prospective, investigator-initiated trial investigated the efficacy and toxicity of a myeloa...

A. O. Saidy, B. Altmann, P. van Heteren et al. · Haematologica · 0 citations